Stockholm, Sweden – A modern study from Karolinska Institutet reveals a significant decline in opioid overdose deaths among individuals participating in needle and syringe programs (NSPs) in Stockholm. Researchers found an 80% reduction in fatalities – dropping from approximately 29 to nearly 6 deaths per 1,000 person-years – between 2013 and 2023. This substantial decrease coincides with the expanded implementation of harm reduction strategies, notably the introduction of take-home naloxone programs.
The findings, published in the Harm Reduction Journal, underscore the critical role of accessible harm reduction interventions in combating the opioid crisis. The study highlights the potential for scaling up these programs to save lives and improve public health outcomes for people who inject drugs.
Researchers followed 4,192 individuals who utilized the Stockholm NSP between April 2013 and March 2023, linking data from the program’s quality register with Sweden’s National Cause of Death Register. Over the study period, 685 individuals (16% of the cohort) died, but overall mortality rates decreased, with the most pronounced change observed in opioid overdose deaths. Opioid overdose was the leading cause of death, accounting for 53% of all fatalities.
Decline Linked to Naloxone Access and Reduced Opioid Use
The marked decline in opioid overdose mortality began around January 2018, coinciding with the implementation of a take-home naloxone (THN) distribution program at the Stockholm NSP. Naloxone is a life-saving medication that can reverse the effects of an opioid overdose. The decrease also occurred alongside a reported reduction in opioid use among program participants.
“We observe a clear decline in opioid overdose deaths over time,” said Elin Holmén, researcher at the Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet. “This strengthens the evidence that broader access to harm reduction interventions can craft a difference.”
Medically Assisted Treatment Also Shows Promise
The study also found that individuals participating in medically assisted treatment (MAT) for opioid dependence – specifically, a program called Laro – experienced lower overall mortality rates and a reduced risk of death due to overdose. This suggests that comprehensive treatment approaches, combining medication with harm reduction strategies, are particularly effective.
Researchers also suggest that supervised consumption sites (SCS), where individuals can use drugs under medical supervision, could further contribute to preventing overdose deaths. These facilities provide a safe environment and immediate access to medical assistance in case of an emergency.
Participants in the Sweden’s first Take-Home Naloxone program demonstrated that stimulant use (aIRR 1.26; 95% CI 1.01, 1.58), benzodiazepine use (aIRR 1.75; 95% CI 1.1, 2.78) and homelessness (aIRR 1.35; 95% CI 1.06, 1.73) were predictors associated with an increased number of reported overdose reversals.
Looking Ahead
The findings from this study reinforce the importance of continued investment in and expansion of harm reduction services, including naloxone distribution and access to MAT. Further research is needed to evaluate the effectiveness of different harm reduction models and to identify best practices for reaching vulnerable populations. The ongoing evaluation of these programs will be crucial in informing public health policy and ultimately saving lives.
What are your thoughts on the role of harm reduction strategies in addressing the opioid crisis? Share your comments below.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
